These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34798569)

  • 1. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
    Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
    Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
    Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
    Leuk Res; 2022 Feb; 113():106786. PubMed ID: 35063283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial toxicity, coping strategies, and quality of life among Chinese patients with hematologic malignancies: a cross-sectional study.
    Wang Y; Luo B; Wang X; Ji Q; Cao X
    Support Care Cancer; 2024 Jul; 32(7):475. PubMed ID: 38954081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial Hardship After Traumatic Injury: Risk Factors and Drivers of Out-of-Pocket Health Expenses.
    O'Neill KM; Jean RA; Gross CP; Becher RD; Khera R; Elizondo JV; Nasir K
    J Surg Res; 2020 Dec; 256():1-12. PubMed ID: 32663705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
    Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
    Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do haematological cancer survivors want help with? A cross-sectional investigation of unmet supportive care needs.
    Hall AE; Sanson-Fisher RW; Lynagh MC; Tzelepis F; D'Este C
    BMC Res Notes; 2015 Jun; 8():221. PubMed ID: 26047620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
    Mejri N; Berrazega Y; Boujnah R; Rachdi H; El Benna H; Labidi S; Boussen H
    Support Care Cancer; 2021 Jul; 29(7):4105-4111. PubMed ID: 33404807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.
    Bailey CM; Asaad M; Boukovalas S; Lin YL; Kothamasu V; Kapur SK; Villa MT; Butler CE; Offodile AC
    Plast Reconstr Surg; 2021 Jul; 148(1):1e-11e. PubMed ID: 34181599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance Coverage, Employment Status, and Financial Well-Being of Young Women Diagnosed with Breast Cancer.
    Tangka FKL; Subramanian S; Jones M; Edwards P; Flanigan T; Kaganova Y; Smith KW; Thomas CC; Hawkins NA; Rodriguez J; Fairley T; Guy GP
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):616-624. PubMed ID: 32132129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
    Ezeife DA; Morganstein BJ; Lau S; Law JH; Le LW; Bredle J; Cella D; Doherty MK; Bradbury P; Liu G; Sacher A; Shepherd FA; Leighl NB
    Clin Lung Cancer; 2019 Jul; 20(4):231-236. PubMed ID: 30797721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial toxicity in gynecologic oncology.
    Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
    Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Lung Cancer on Health-Related Quality of Life, Financial Toxicity, and Household Economics in Patients From the Public and the Private Healthcare Sector in Argentina.
    Augustovski F; Tsou F; González L; Martín C; Vigo S; Gabay C; Alcaraz A; Argento F
    Value Health Reg Issues; 2024 May; 41():94-99. PubMed ID: 38290167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
    Durber K; Halkett GK; McMullen M; Nowak AK
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Economic Impact on Australian Patients with Neuroendocrine Tumours.
    Gordon LG; Elliott TM; Wakelin K; Leyden S; Leyden J; Michael M; Pavlakis N; Mumford J; Segelov E; Wyld DK
    Patient; 2020 Jun; 13(3):363-373. PubMed ID: 32072460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review.
    Parker C; Berkovic D; Ayton D; Zomer E; Liew D; Wei A
    Curr Oncol; 2022 May; 29(6):3807-3824. PubMed ID: 35735414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personal financial effects of multiple myeloma and its treatment.
    Goodwin JA; Coleman EA; Sullivan E; Easley R; McNatt PK; Chowdhury N; Stewart CB
    Cancer Nurs; 2013; 36(4):301-8. PubMed ID: 23047800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Cost-Related Delays to Medical Care Among Lymphoma Patients: A 22-Year Analysis of a Nationally Representative Sample.
    Jella TK; Cwalina TB; Treisman J; Hamadani M
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):e619-e625. PubMed ID: 33785298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China.
    Jing J; Feng R; Zhang X; Li M; Gao J
    Breast Cancer Res Treat; 2020 Jun; 181(2):435-443. PubMed ID: 32306169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
    Huey RW; George GC; Phillips P; White R; Fu S; Janku F; Karp DD; Naing A; Piha-Paul S; Subbiah V; Tsimberidou AM; Pant S; Yap TA; Rodon J; Meric-Bernstam F; Shih YT; Hong DS
    Oncologist; 2021 Jul; 26(7):588-596. PubMed ID: 33783054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
    Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
    BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.